HANGZHOU ALLTEST BIOTECH CO LTD
Hangzhou AllTest Biotech is a Chinese IVD manufacturer that designs, produces, and distributes 900+ rapid point-of-care diagnostic cassettes and reader instruments across infectious disease, cardiac, women's health, veterinary, and adjacent medical device lines, serving global clinical and point-of-care markets via channel partners.
- Company typePrivate
- Founded2009
- HeadquartersHangzhou, China
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What HANGZHOU ALLTEST BIOTECH CO LTD does
Hangzhou AllTest Biotech Co., Ltd. is a Chinese in-vitro diagnostic (IVD) manufacturer that designs, produces, and distributes rapid point-of-care testing (POCT) devices and consumables. Founded in 2009 and headquartered in the Hangzhou Economic and Technological Development Area, the company is publicly listed on the Shanghai Stock Exchange (sse:688606) and operates with 101-250 employees. Its portfolio spans ten product lines covering lateral flow immunoassay, fluorescence immunoassay, dry biochemistry, chemiluminescence immunoassay, PCR, immunoblotting, blood grouping reagents, COVID-19 solutions, veterinary diagnostics, and adjacent medical devices (Gastrointestinal Mucosal Healing Gel, Laryngeal Mask Airway), totaling more than 900 IVD SKUs, 79 related patents, and 708 CE certifications under ISO 13485 and EU IVDR compliance.
The company's underlying technology architecture is a multi-platform immunoassay and molecular diagnostic stack. Lateral flow cassettes deliver qualitative results in roughly ten minutes with two-year shelf life and room-temperature storage; the LF Reader, FIA Immunofluorescence Analyzer, and EZCHEK urine analyzer upgrade selected tests to semi-quantitative or quantitative readouts, establishing a razor-and-blade consumables model. Newer launches (Multiplex Respiratory Antigen, CARBA-5, hs-cTnT, COPD, mineral/vitamin panels, HIV 1.2, Cortisol, Feline Blood Typing) extend the menu across infectious disease, antimicrobial resistance, cardiac markers, women's health, endocrine, and veterinary segments.
Commercially, AllTest monetizes through unit-priced cassette and instrument sales, with no public price list (transactions handled via direct contact). Go-to-market is event-driven and channel-partner-led: the company maintains a continuous presence at top-tier medical exhibitions (MEDICA, Arab Health, HOSPITALAR, AACC, CMEF, CACLP, WHX Labs/Miami, Medical Fair Asia, Thailand Medical Fair, Medical Philippines Expo) to onboard and grow distributor relationships across China, the EU, the Middle East, Latin America, Southeast Asia, and increasingly the Americas. A 2022 strategic cooperation agreement with Zhende Medical addressed COVID-19 demand, and EU IVDR registration in August 2022 secured continued European market access. The management team is led by Fei Gao (Soar Gao) as Founder, Chairman, and General Manager.
HANGZHOU ALLTEST BIOTECH CO LTD firmographics
Firmographics- Name
- HANGZHOU ALLTEST BIOTECH CO LTD
- Legal name
- HANGZHOU ALLTEST BIOTECH CO.,LTD
- Website
- https://alltests.com.cn
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Hangzhou AllTest Biotech is a Chinese IVD manufacturer that designs, produces, and distributes 900+ rapid point-of-care diagnostic cassettes and reader instruments across infectious disease, cardiac, women's health, veterinary, and adjacent medical device lines, serving global clinical and point-of-care markets via channel partners.
- Ownership category
- akta.pro rank
HANGZHOU ALLTEST BIOTECH CO LTD industry classification
Industry- Product category
- In-Vitro Diagnostics (IVD)
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)
- akta.pro secondary industries
- Immunoassay Diagnostics (ELISA, chemiluminescence, serology) (HLAAALAB), Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI)
Keywords
Where HANGZHOU ALLTEST BIOTECH CO LTD is headquartered
LocationHeadquarters
- HQ city
- Hangzhou
- HQ country
- China
- HQ region
- Asia
Markets served
HANGZHOU ALLTEST BIOTECH CO LTD business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Diagnostic rapid test kit (cassette) sales: Sale of single-use lateral flow and immunoassay test cassettes (e.g., 25 T packs, cat. No. INMC-425) across infectious disease, cardiac markers, fertility, drugs-of-abuse, tumor markers, women's health, and veterinary lines. Unit-priced hardware/ consumable sales model.
- Analyzer / LF Reader instrument sales: Sale of FIA immunofluorescence analyzers, EZCHEK urine strip analyzer, and LF Reader instruments enabling semi-quantitative/quantitative detection, paired with the consumables business.
- Veterinary diagnostic test sales: Sales of specialized veterinary diagnostic solutions including Feline Blood Typing Rapid Test, FIV/FELV Combo Rapid Test, and tests for feline, canine and porcine species.
- Medical device adjuncts (GI gel, Laryngeal Mask Airway) sales: Sales of unique medical device solutions (Gastrointestinal Mucosal Healing Gel, Laryngeal Mask Airway) extending beyond diagnostics into consumable medical devices for clinical workflows.
Go-to-market motion3 records
HANGZHOU ALLTEST BIOTECH CO LTD product offering
Product offeringCore offering
Hangzhou AllTest Biotech designs, manufactures, and globally distributes a comprehensive portfolio of in-vitro diagnostic (IVD) rapid test cassettes and accompanying analyzer instruments spanning lateral flow immunoassay, fluorescence immunoassay, dry biochemistry, chemiluminescence immunoassay, PCR molecular diagnostics, and immunoblotting technologies. The portfolio covers infectious disease, cardiac markers, tumor markers, women's health, drugs of abuse, fertility, veterinary, and blood grouping applications, supported by ISO 13485, EU IVDR, and CE compliance. The company sells through international exhibitions, regional distributors, and direct B2B sales across more than 900 IVD diagnostic SKUs.
Product overview
HANGZHOU ALLTEST BIOTECH CO.,LTD offers a comprehensive in-vitro diagnostic (IVD) and point-of-care testing (POCT) portfolio delivered as a modular platform-plus-product-lines architecture. The portfolio spans ten product lines — COVID-19 Solution, Human Rapid Test, LF Reader, Veterinary, Fluorescence, Biochemistry, PCR, Immunoblotting, Chemiluminescence, and Blood Grouping Reagents — covering lateral-flow immunoassay, fluorescence immunoassay, dry biochemistry, chemiluminescence immunoassay, PCR, and immunoblotting technologies. Individual diagnostic cassettes within these lines include featured products such as the High-Sensitivity Cardiac Troponin T Test Cassette, High-Sensitivity NT-proBNP Test Cassette, Lp-PLA2 Test Cassette, CA125 Test Cassette, Insulin Test Cassette, Folate Test Cassette, Vitamin B12 Test Cassette, ASO Test Cassette, Typhoid Test Cassette, Malaria P.f./P.v./Pan Test Cassette, the COVID-19 and M.pneumoniae IgG/IgM Combo Rapid Test, the Influenza A/B+H1N1+H5N1 Antigen Combo Rapid Test, the Syphilis Rapid Test, the Dengue IgG/IgM and NS1 Combo Rapid Test, the FIV/FELV Combo Rapid Test, and the Drink Check Test, complemented by reader instruments such as the LF Reader, the FIA Immunofluorescence Analyzer, and the EZCHEK Urine Test Analyzer. Recently launched items (2026) include the Multiplex Respiratory Antigen Rapid Test, CARBA-5 and COPD Rapid Tests, Zinc/Calcium/Magnesium Tests, HIV 1.2 and Cortisol Rapid Tests, Feline Blood Typing Rapid Test, Gastrointestinal Mucosal Healing Gel, and Laryngeal Mask Airway. The portfolio is supported by 79 related patents, 708 CE certifications, and 900+ IVD diagnostics, manufactured under ISO 13485 and EU IVDR compliance.
Differentiator
Problem solved
Functional benefit
Products and services
- COVID-19 Solution Dedicated product line of COVID-19 diagnostic rapid tests including COVID-19 Antigen Test, COVID-19 Antigen Combo Rapid Test, COVID-19 Antibody Test, and COVID-19 Antibody Combo Rapid Test for SARS-CoV-2 detection, targeting hospitals, labs, enterprise screening, and retail self-testing channels.
- Human Rapid Test Broad lateral-flow rapid IVD product line for humans covering infectious diseases, cardiac markers, tumor markers, women's health, drugs of abuse, and other clinical conditions, with 900+ diagnostics across the overall IVD catalog.
- LF Reader Companion reader instrument that upgrades lateral flow drug-detection and other rapid tests from qualitative to semi-quantitative or quantitative results.
- Veterinary Rapid diagnostic test product line for veterinary use covering feline, canine, and porcine species, including FIV/FELV Combo Rapid Tests, Feline Blood Typing Rapid Test, and Vecheck animal products.
- Fluorescence Fluorescence immunoassay (FIA) rapid tests paired with the FIA Immunofluorescence Analyzer for quantitative point-of-care diagnostics covering infection, cardiac markers, and coagulation testing.
- Biochemistry Dry biochemistry rapid test product line including the EZCHEK urine test analyzer for clinical biochemistry and urine screening.
- PCR Molecular diagnostic PCR products for nucleic acid-based testing as part of the comprehensive IVD portfolio.
- Immunoblotting Immunoblotting diagnostic test product line as part of the comprehensive test platform offering.
- Chemiluminescence Chemiluminescence immunoassay (CLIA) diagnostic platform supporting higher-sensitivity immunoassay testing within the AllTest product family.
- Blood Grouping Reagents Blood grouping reagent product line for blood typing applications as part of the comprehensive IVD portfolio.
- FIA Immunofluorescence Analyzer FIA analyzer instrument for quantitative immunoassay testing in clinical laboratories and point-of-care settings, paired with fluorescence immunoassay test panels.
- EZCHEK Urine Test Analyzer Urine strip analyzer instrument for clinical urine testing in laboratory and point-of-care settings.
- COVID-19 and M.pneumoniae IgG/IgM Combo Rapid Test Chromatographic immunoassay cassette for qualitative detection of IgG and IgM antibodies to SARS-CoV-2 and Mycoplasma pneumoniae in whole blood, serum, or plasma; CE certified, 10-minute read time, 25 tests per pack, 2-year shelf life.
- High-Sensitivity Cardiac Troponin T Test Cassette High-sensitivity cardiac troponin T (hs-cTnT) test cassette for early rule-out and accelerated diagnostic protocols of myocardial infarction, targeted at clinical and point-of-care cardiac diagnostics.
- Multiplex Respiratory Antigen Rapid Test Multiplex respiratory antigen combo rapid test that detects multiple respiratory pathogens on a single cassette, for clinical diagnostics and point-of-care testing.
- CARBA-5 Rapid Test Rapid test for carbapenem-resistant Enterobacteriaceae (CARBA-5), addressing multidrug-resistant organisms as an urgent antimicrobial resistance threat, targeted at antimicrobial resistance and infection control diagnostics.
- Feline Blood Typing Rapid Test Veterinary rapid test for blood typing in feline species, used by veterinary professionals for cats.
- COPD Rapid Test Rapid test for chronic obstructive pulmonary disease (COPD) screening in clinical diagnostics and point-of-care settings.
- Gastrointestinal Mucosal Healing Gel Adjunct medical device solution (gastrointestinal mucosal healing gel) for clinical and hospital gastrointestinal care workflows.
- Laryngeal Mask Airway Adjunct medical device solution (laryngeal mask airway) for anesthesia and emergency airway management in clinical settings.
- Zinc Test Rapid test for zinc deficiency detection in clinical point-of-care diagnostics.
- Calcium Test Rapid test for calcium level detection in clinical point-of-care diagnostics.
- Magnesium Test Rapid test for magnesium level detection in clinical point-of-care diagnostics.
- HIV 1.2 Rapid Test Rapid test for HIV 1.2 antibody detection in infectious disease screening.
- Cortisol (COR) Rapid Test Rapid test for cortisol (COR) level detection in clinical point-of-care diagnostics.
- Drink Check Test Drink-check rapid test for drug-spiked beverage detection in drugs-of-abuse screening.
- Multi-Drug Panels Versatile multi-drug rapid test panels for drugs-of-abuse screening in clinical and workplace testing.
Companies that use HANGZHOU ALLTEST BIOTECH CO LTD
Customer profileIdeal customer profiles4 records
HANGZHOU ALLTEST BIOTECH CO LTD technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature9 records
HANGZHOU ALLTEST BIOTECH CO LTD partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights6 records
HANGZHOU ALLTEST BIOTECH CO LTD competitors and assessment
Company assessmentDirect peers
- SD Biosensor: Korea-based IVD manufacturer with a broad rapid diagnostic test franchise (COVID-19, influenza, cardiac, hemoglobin A1c) and global distribution across LATAM, EMEA, and Asia. Strongest direct comp on multi-platform IVD offering and exhibition-centric GTM.
- CTK Biotech: US-based IVD company specializing in rapid diagnostic tests for infectious disease, fertility, DOA, and tropical diseases, distributed via OEM and international partners. Direct comp on cassette-based product mix and emerging-market focus.
- ACON Laboratories: US-headquartered IVD manufacturer with an extensive lateral flow rapid-test portfolio (infectious disease, cardiac, DOA, women's health) distributed globally through OEM and distributor channels. Direct competitor on SKU breadth and international distribution model.
- Guangzhou Wondfo Biotech: Chinese-listed IVD manufacturer (300482.SZ) with a comparable lateral flow immunoassay cassette portfolio covering infectious disease, cardiac markers, fertility, and drugs-of-abuse. Closest direct comp on product mix, scale, and channel-partner-led international GTM.
- Zhejiang Orient Gene Biotech: Hangzhou-based IVD manufacturer with a deep rapid-test cassette franchise (COVID-19, infectious disease, DOA) and global distribution. Comparable in product scope, geographic focus, and exhibition-driven international expansion.
- Hangzhou Biotest Biotech (Biotest Hangzhou / Joinstar Biomed): Chinese IVD player focused on rapid diagnostic reagents including COVID-19, cardiac markers, and inflammation. Competes head-to-head with AllTest in cassette-based lateral flow immunoassays for hospital and POCT channels.
Broad incumbents
- Bio-Rad Laboratories: Diversified life-science tools and clinical diagnostics player with rapid-test kits, immunoassay instruments, and quality controls. Comparable on the immunoassay consumables side and as an indirect competitor for hospital lab budgets.
- Abbott Rapid Diagnostics: Global IVD leader with Panbio, Binax, and Determine rapid-test franchises plus higher-ASP ARCHITECT and Alinity platforms. Sets the pricing and quality benchmark that AllTest's cassette portfolio competes against in distributor catalogs.
- QuidelOrtho: US-listed IVD major with leading Sofia lateral flow rapid-test platform and a broader immunoassay and clinical chemistry portfolio. Competes with AllTest in rapid infectious disease and cardiac diagnostics globally.
Emerging players
- Innovita (Tianjin) Biotechnology: Chinese IVD company with respiratory, infectious disease, and women's health rapid-test products. Comparable on Asian-market cassette portfolio but smaller scale and narrower geographic footprint than AllTest.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
HANGZHOU ALLTEST BIOTECH CO LTD social profiles
Digital presenceHANGZHOU ALLTEST BIOTECH CO LTD compliance and trust
Trust signalCompliance5 records
HANGZHOU ALLTEST BIOTECH CO LTD financial estimates
Financial estimateRevenue estimate
Valuation estimate
HANGZHOU ALLTEST BIOTECH CO LTD leadership team
Management profileNumber of profiles
Profiles1 record
HANGZHOU ALLTEST BIOTECH CO LTD funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
HANGZHOU ALLTEST BIOTECH CO LTD M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about HANGZHOU ALLTEST BIOTECH CO LTD
What does HANGZHOU ALLTEST BIOTECH CO LTD do?
Hangzhou AllTest Biotech designs, manufactures, and globally distributes a comprehensive portfolio of in-vitro diagnostic (IVD) rapid test cassettes and accompanying analyzer instruments spanning lateral flow immunoassay, fluorescence immunoassay, dry biochemistry, chemiluminescence immunoassay, PCR molecular diagnostics, and immunoblotting technologies. The portfolio covers infectious disease, cardiac markers, tumor markers, women's health, drugs of abuse, fertility, veterinary, and blood grouping applications, supported by ISO 13485, EU IVDR, and CE compliance. The company sells through international exhibitions, regional distributors, and direct B2B sales across more than 900 IVD diagnostic SKUs.
Is HANGZHOU ALLTEST BIOTECH CO LTD a public or private company?
HANGZHOU ALLTEST BIOTECH CO LTD is a private company. It is classified as public and is currently operating.
When was HANGZHOU ALLTEST BIOTECH CO LTD founded?
HANGZHOU ALLTEST BIOTECH CO LTD was founded in 2009. It employs 101 to 250 people.
Where is HANGZHOU ALLTEST BIOTECH CO LTD based?
HANGZHOU ALLTEST BIOTECH CO LTD is headquartered in Hangzhou, China, in the Asia region.
How does HANGZHOU ALLTEST BIOTECH CO LTD make money?
Four revenue lines are on record. Diagnostic rapid test kit (cassette) sales are the primary driver. The others are analyzer / LF Reader instrument sales, veterinary diagnostic test sales and medical device adjuncts (GI gel, Laryngeal Mask Airway) sales.
Who are HANGZHOU ALLTEST BIOTECH CO LTD's main competitors?
Direct peers on record are SD Biosensor, CTK Biotech, ACON Laboratories, Guangzhou Wondfo Biotech, Zhejiang Orient Gene Biotech and Hangzhou Biotest Biotech (Biotest Hangzhou / Joinstar Biomed). Broad incumbents are Bio-Rad Laboratories, Abbott Rapid Diagnostics and QuidelOrtho. Innovita (Tianjin) Biotechnology is listed as an emerging player.
Does HANGZHOU ALLTEST BIOTECH CO LTD have an API?
No public API is recorded for HANGZHOU ALLTEST BIOTECH CO LTD.
What industry is HANGZHOU ALLTEST BIOTECH CO LTD in?
HANGZHOU ALLTEST BIOTECH CO LTD's product category is In-Vitro Diagnostics (IVD). Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAAALAB, Immunoassay Diagnostics (ELISA, chemiluminescence, serology). Its NAICS code is 325413 and its SIC code is 2835.